Nemaura Medical Analyst Ratings
Nemaura Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/19/2022 | 268.66% | HC Wainwright & Co. | $12 → $8 | Maintains | Buy |
| 03/29/2022 | 453% | HC Wainwright & Co. | → $12 | Initiates Coverage On | → Buy |
| 12/02/2021 | 245.62% | EF Hutton | → $7.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2022 年 8 月 19 日 | 268.66% | HC Wainwright & Co. | 12 美元 → 8 美元 | 維護 | 買 |
| 03/29/2022 | 453% | HC Wainwright & Co. | → 12 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2021 年 2 月 12 日 | 245.62% | EF Hutton | → 7.5 美元 | 啓動覆蓋範圍開啓 | → 購買 |
Nemaura Medical Questions & Answers
Nemaura 醫療問題與解答
The latest price target for Nemaura Medical (NASDAQ: NMRD) was reported by HC Wainwright & Co. on August 19, 2022. The analyst firm set a price target for $8.00 expecting NMRD to rise to within 12 months (a possible 268.66% upside). 3 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2022年8月19日公佈了內毛拉醫療（納斯達克股票代碼：NMRD）的最新目標股價。該分析公司將目標股價定爲8.00美元，預計NMRD將在12個月內升至12個月內（可能上漲268.66％）。去年有3家分析公司公佈了評級。
The latest analyst rating for Nemaura Medical (NASDAQ: NMRD) was provided by HC Wainwright & Co., and Nemaura Medical maintained their buy rating.
HC Wainwright & Co. 對Nemaura Medical（納斯達克股票代碼：NMRD）的最新分析師評級由HC Wainwright & Co. 提供，Nemaura Medical維持買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nemaura Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nemaura Medical was filed on August 19, 2022 so you should expect the next rating to be made available sometime around August 19, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Nemaura Medical的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Nemaura Medical的最新評級是在2022年8月19日公佈的，因此您應該預計下一個評級將在2023年8月19日左右公佈。
While ratings are subjective and will change, the latest Nemaura Medical (NMRD) rating was a maintained with a price target of $12.00 to $8.00. The current price Nemaura Medical (NMRD) is trading at is $2.17, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Nemaura Medical（NMRD）評級維持不變，目標股價爲12.00美元至8.00美元。Nemaura Medical（NMRD）目前的交易價格爲2.17美元，超出了分析師的預期區間。